<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">325337</id>
  <title nil="true"/>
  <common-name>2-[[4-(4-bromophenyl)-5-pyridin-3-yl-1,2,4-triazol-3-yl]sulfanyl]-n-(3-chlorophenyl)acetamide</common-name>
  <description>2-[[4-(4-bromophenyl)-5-pyridin-3-yl-1,2,4-triazol-3-yl]sulfanyl]-n-(3-chlorophenyl)acetamide is a chemical compound with the formula C21H15BrClN5OS. With an average molecular weight of 500.80 g/mol, 2-[[4-(4-bromophenyl)-5-pyridin-3-yl-1,2,4-triazol-3-yl]sulfanyl]-n-(3-chlorophenyl)acetamide is a heavy molecule.</description>
  <cas>763108-61-8</cas>
  <pubchem-id>1886930</pubchem-id>
  <chemical-formula>C21H15BrClN5OS</chemical-formula>
  <weight>500.8</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T03:02:48Z</created-at>
  <updated-at type="dateTime">2026-08-30T03:02:48Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1=CC(=CC(=C1)Cl)NC(=O)CSC2=NN=C(N2C3=CC=C(C=C3)Br)C4=CN=CC=C4</moldb-smiles>
  <moldb-formula>C21H15BrClN5OS</moldb-formula>
  <moldb-inchi>InChI=1S/C21H15BrClN5OS/c22-15-6-8-18(9-7-15)28-20(14-3-2-10-24-12-14)26-27-21(28)30-13-19(29)25-17-5-1-4-16(23)11-17/h1-12H,13H2,(H,25,29)</moldb-inchi>
  <moldb-inchikey>BZFHWFSKDDZOPU-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">498.98692</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4.7</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM321230</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[[4-(4-bromophenyl)-5-pyridin-3-yl-1,2,4-triazol-3-yl]sulfanyl]-n-(3-chlorophenyl)acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Pyridines and derivatives</klass>
  <subklass>Pyridyltriazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0275976</sync-id>
  <structure-inchikey>BZFHWFSKDDZOPU-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4000200000800000000800000000000400008100000080004000004000000000000000000004008000002080000000000004000000000000000000000000000000400000008000000000000020000000000001000000808010000000000000010000000000000000100000040400000100000000000000000000000001100000000000800000000080000084880000010000000000000000000000000000000000000000000000080000000000000000410000000000002c00000100000000000020001000000100004000100010000000002000000200000000000000008040000000002040000000000400000000010000000040000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle>ï¾­Þ��������������������!���€��@h�������@h�������@(������@h�������@(������@h�������� ������h��������(�������(�������`������� �����@(������@(������@(������@(������@(������@(������@h�������@h�������@(������@h�������@h������#� �����@(������@h�������@(������@h�������@h�������@h���������h���h���h���h���h������ �� �	(��
�
������h��h���h���h��� ��h���h���h���h���h������ ��h���h���h���h���h���h���h���h���h�B����������������������������������������</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:29:15Z</structure-indexed-at>
</compound>
